Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

Shigeki Takemoto, MD, Michihiro Hidaka, MD, Shoichi Nagakura, MD, Tatsunori Sakai, MD, Takahiro Matsui, MD, Toshiro Kawakita, MD, Yoshiko Inoue, MD, Atsuko Tsukamoto, MD, Tetsuyuki Kiyokawa, MD, Fumio Kawano, MD

Blood (2007) 110 (11): 5037.

https://doi.org/10.1182/blood.V110.11.5037.5037

Published: 2007

Journal Articles

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Tomoko Nanri, MD, PhD, Eisaku Iwanaga, MD, Naofumi Matsuno, MD, PhD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, PhD, Fumio Kawano, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2007) 110 (11): 3492.

https://doi.org/10.1182/blood.V110.11.3492.3492

Published: 2007

Journal Articles

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Tomoko Nanri, MD, Naokuni Uike, MD, Toshiro Kawakita, MD, Eisaku Iwanaga, MD, Koyu Hoshino, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2006) 108 (11): 1916.

https://doi.org/10.1182/blood.V108.11.1916.1916

Published: 2006

Journal Articles

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Tomoko Nanri, MD, Toshiro Kawakita, MD, Koyu Hoshino, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD, Naokuni Uike, MD

Blood (2005) 106 (11): 4564.

https://doi.org/10.1182/blood.V106.11.4564.4564

Published: 2005

Journal Articles

Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).

Tomoko Nanri, MD, Naofumi Matsuno, MD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, Fumio Kawano, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2004) 104 (11): 3000.

https://doi.org/10.1182/blood.V104.11.3000.3000

Published: 2004

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).

Email alerts

ASH Publications

American Society of Hematology

Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene.

Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only